THE AMYLOIDOSIS FOUNDATION
Income Statement
Fiscal Year Start:
Jan 1
Revenues in 2024
$688,539
Contributions
85%
Other
10%
Investments
5%
Government Grants
0%
Fundraising Events
0%
Program Services
0%
Membership Dues
0%
Expenses in 2024
$602,526
Other
36%
Salaries & Benefits
31%
Grants
28%
Fees to Service Providers
3%
Offices, Occupancy & IT
2%
Depreciation
<1%
Benefits to Members
0%
Advertising & Promotion
0%
Interest
0%
Revenues
2023
2024
Change
Contributions
$463,050
$583,395
+26%
Government Grants
$0
$0
-
Fundraising Events
$0
$0
-
Program Services
$0
$0
-
Membership Dues
$0
$0
-
Investments
$24,762
$37,716
+52%
Other
$47,350
$67,428
+42%
Total Revenues
$535,162
$688,539
+29%
Expenses
2023
2024
Change
Grants
$180,000
$166,725
-7%
Benefits to Members
$0
$0
-
Salaries & Benefits
$183,772
$186,548
+2%
Fees to Service Providers
$20,684
$17,472
-16%
Advertising & Promotion
$0
$0
-
Offices, Occupancy & IT
$13,290
$13,388
+1%
Interest
$0
$0
-
Depreciation
$1,927
$2,135
+11%
Other
$169,247
$216,258
+28%
Total Expenses
$568,920
$602,526
+6%
Net income
2023
2024
Change
Net income
-$33,758
+$86,013
-355%
Functional Expenses
Summary
2023
2024
Change
Program
$445,587
$482,169
+8%
Admin
$47,777
$62,428
+31%
Fundraising
$75,556
$57,929
-23%
Total Expenses
$568,920
$602,526
+6%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)